US · Healthcare · Health Information Services
EPS came in at 2.24 against a street estimate of 2.14 — a beat of 4.7%.
Analysts rate Veeva Systems Inc Class A a buy (19 buy, 11 hold, 2 sell out of 32) with an average price target of $244.14.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.08% |
| Vanguard Portfolio Management, LLC | 4.52% |
| Vanguard Capital Management, LLC | 4.09% |
| AllianceBernstein L.P. | 3.84% |
| Linonia Partnership LP | 3.02% |
| Principal Financial Group Inc | 2.54% |
| State Street Corp | 2.21% |
| T. Rowe Price Investment Management,Inc. | 2.09% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 2026 | 2026-06-18 |
| Quarterly report · Q2 2026 | 2026-06-05 |
| Results announced · Q2 2026 | 2026-06-03 |
| Proxy statement · Q2 2026 | 2026-05-04 |
| Board / officer change · Q2 2026 | 2026-04-20 |
| Annual report FY2026 | 2026-03-20 |
| Results announced · Q1 2026 | 2026-03-04 |
| Quarterly report · Q4 2025 | 2025-11-21 |
Readable in the app.
| Announcement | Date |
|---|---|
| Board authorizes $2 billion share repurchase program over 2 years Veeva Systems announced on January 5, 2026 that its Board authorized a $2 billion share repurchase program for its Class A common stock. The program has a 2-year term and is flexible—managem | 2026-01-05 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Veeva Systems Inc Class A — free to start.
Google PlayApp StoreData updated 2026-08-05.